根據報導 Semler Scientific 購買了價值 2,150 萬美元的比特幣

據報道，一家透過其技術解決方案 Semler Scientific 在慢性病管理領域處於領先地位的知名公司將根據該公司的長期財務計劃購買價值 2,150 萬美元的比特幣。

Semler Scientific (NYSE: SMLR), a company renowned for its technological solution in chronic condition management, is reportedly deploying an additional $21.5 million in Bitcoin (BTC) as part of its long-term financial strategy. This latest purchase aligns with the company's broader commitment to a BTC treasury program, which was launched earlier in 2024.

Semler Scientific（NYSE：SMLR）是一家以其慢性病管理技術解決方案而聞名的公司，據報道，作為其長期財務戰略的一部分，該公司將額外部署2150 萬美元的比特幣(BTC )。此次最新購買符合該公司對 2024 年初推出的 BTC 金庫計畫的更廣泛承諾。

According to the recent filing, Semler Scientific has calculated the purchase of 211 Bitcoins, averaging at a market value of $101,890, for a total cost of $21.5 million. The company has also showcased impressive growth in Bitcoin yield with this purchase, reporting a quarterly yield of 67.0%, bringing its total yield to 92.8% since implementing the BTC treasury plan in May 2024.

根據最近提交的文件，Semler Scientific 計算出購買了 211 個比特幣，平均市場價值為 101,890 美元，總成本為 2,150 萬美元。透過此次購買，該公司的比特幣收益率也實現了令人印象深刻的成長，季度收益率為 67.0%，自 2024 年 5 月實施 BTC 國庫計劃以來，其總收益率達到 92.8%。

Semler's Bitcoin Drive Pushes Up Available Shares

塞姆勒的比特幣推動推高了可用股票

The company's strategy, which now includes 2,084 BTC at a cost of $168.6 million, highlights the increasing trend of cryptocurrency forming a substantial part of capital markets strategy. This is especially noteworthy for a company focused on chronic illness technology solutions, actively pursuing diversification.

該公司的策略目前包括 2,084 比特幣，成本為 1.686 億美元，凸顯了加密貨幣日益成為資本市場戰略重要組成部分的趨勢。對於一家專注於慢性病技術解決方案、積極追求多元化的公司來說，這一點尤其值得注意。

Semler Scientific increased its maximum available shares under the at-the-market (ATM) offering to $150 million, effective December 16, 2024. The firm had achieved $100 million by December 13, 2024. It also entered an agreement with Cantor Fitzgerald & Co. to use a Controlled Equity Offering.

Semler Scientific 將其在市場(ATM) 發行下的最大可用股票增加至1.5 億美元，自2024 年12 月16 日起生效。 。

With the Bitcoin addition, Semler has also significantly increased its share count. The outstanding shares have increased from 6.99 million in June 2024 to 9.27 million as of December 2024. The diluted shares came to 9.97 million. Semler noted that while this has increased, multiple factors impact the stock price. He highlighted that the value of the Bitcoins owned is only one of those factors.

隨著比特幣的加入，Semler 的股份數量也大幅增加。已發行股份從2024年6月的699萬股增加到截至2024年12月的927萬股。塞姆勒指出，雖然這數字有增加，但影響股價的因素有很多。他強調，所擁有的比特幣的價值只是這些因素之一。

Semler continues to showcase a commitment to its cryptocurrency strategy, considering it an essential element of its overall financial vision. However, the company clarifies its BTC Yield as not a measure of performance results for shareholders. It guides management by showing which strategy has been initiated to help achieve long-term shareholder value.

Semler 繼續展現對其加密貨幣策略的承諾，認為這是其整體財務願景的重要組成部分。然而，該公司澄清其比特幣收益率並不是衡量股東績效的指標。它透過顯示已啟動哪些策略來幫助實現長期股東價值來指導管理層。

MicroStrategy is a large entity, it holds a lot of Bitcoin, but the more critical consideration is in the strategic standpoint, and for Semler Scientific, the focus still leans on Bitcoin as the strong foundation of its long-run growth.

MicroStrategy是一個龐大的實體，它持有大量的比特幣，但更關鍵的考慮是在戰略角度，而對於Semler Scientific來說，重點仍然依靠比特幣作為其長期成長的堅實基礎。